Kohle Dr. Mann

Activated charcoal, the active ingredient in Kohle Dr. Mann, is an adsorbent presented as an oral powder for oral use. It is employed in the treatment of acute poisoning and to relieve flatulence and bloating by binding toxins and gases within the gastrointestinal tract.

GNH USA supplies Kohle Dr. Mann as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution across multiple regions.

Activated charcoal is an intestinal decontaminant that binds toxins and gases in the gastrointestinal tract.

- Acute poisoning: reduces systemic absorption of ingested toxins, aiding clinical management. - Drug overdose: adsorbs oral medications to limit their bioavailability. - Flatulence and bloating: binds intestinal gas, providing symptomatic relief. - Gastric decontamination: employed in emergency care to limit absorption of ingested poisons before they reach the intestines. - Intestinal gas: adsorbs excess gas to alleviate discomfort associated with dyspepsia.

Activated charcoal may cause several adverse reactions, most of which are related to its physical properties and gastrointestinal interaction.

Common Side Effects: - Constipation: hard stools may develop due to the bulk of charcoal. - Black stools: feces often appear dark or tar‑colored. - Nausea: mild stomach upset can occur after ingestion. - Vomiting: occasional emesis, especially if taken on an empty stomach. - Abdominal discomfort: cramping or bloating may be reported.

Serious or Rare Side Effects: - Aspiration: risk of inhalation if vomiting occurs, leading to respiratory complications. - Intestinal obstruction: large doses may cause blockage, particularly in patients with pre‑existing GI disorders. - Allergic reaction: rare hypersensitivity manifesting as rash, itching or swelling.

When using activated charcoal, certain precautions should be observed to ensure safety and effectiveness. - Medical supervision: use in acute poisoning only under professional guidance. - Timing of administration: give as soon as possible after toxin ingestion for optimal effect. - Not for charcoal ingestion: avoid use when the patient has ingested charcoal‑containing substances. - Interaction with other meds: separate dosing by at least 2 hours from other oral medications. - Patients with compromised airway: avoid in individuals at risk of aspiration. - Pediatric use: limit to children under medical advice, dosing must be individualized. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Activated charcoal can affect the absorption of various drugs, leading to clinically relevant interactions.

Major Interactions (Avoid): - Warfarin: charcoal may reduce anticoagulant effect, increasing clot risk. - Oral contraceptives: decreased hormone absorption can lead to contraceptive failure. - Lithium: reduced bioavailability may precipitate lithium toxicity.

Moderate Interactions (Monitor Closely): - Iron supplements: adsorption may lower iron levels; monitor hematologic parameters. - Tetracycline antibiotics: charcoal can diminish antibiotic efficacy; consider spacing doses.